2,5-Dihydroxy-3-undecyl-[1,4]benzoquinone, 97.0%, 1g

(4-(Phenylcarbamoyl)phenyl)boronic acid, 95.0%, 5g

1,4,6,7-tetrahydroimidazo[4,5-e][1,4]diazepine-5,8-dione, 90.0%, 1g

2,2'-(2,5-Difluoro-1,4-phenylene)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane), 97%, 10g

5-(4-methylphenyl)-3-[(oxolan-2-yl)methyl]-2-sulfanylidene-1H,2H,3H,4H-thieno[2,3-d]pyrimidin-4-one, 98%, 250mg

Methyl 2-oxo-1,2-dihydroquinoline-3-carboxylate, 95.0%, 1g

Methyl 3-Oxo-4-phenylbutyrate (mixture of isomers)>96.0%(GC)1g

SULFAQUINOXALINE, 96%, 250mg

(1S,2S)-Cyclopropane-1,2-dicarboxylic acid, 95.0%, 100mg

5-Phenyl-1-pentanol>98.0%(GC)5g

calcium (2S)-2-{[4-({[(6S)-2-amino-5-formyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]formamido}pentanedioate, 99.52%, 2g

(6-oxopyridazin-1(6{H})-yl)acetic acid, 95.0%, 250mg

(S)-2-Phenylpyrrolidine, 95.0%, 100mg